Pfizer's Investment Arm Snags $600M With Eye On Biotechs
Pharmaceutical giant Pfizer Inc. on Wednesday revealed plans to plug $600 million into its private investment arm in order to invest in biotechnology and other emerging growth companies in the life...To view the full article, register now.
Already a subscriber? Click here to view full article